A method, system, apparatus, and medium for identifying conserved circRNAs

By constructing and aligning the cross-reverse splice site sequences of circRNAs, the challenge of conservation analysis of circRNAs across species was solved, enabling more accurate homology analysis and supporting the discovery of targets for disease diagnosis and treatment.

CN115588466BActive Publication Date: 2026-11-17HANGZHOU LC BIOTECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211357634.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-11-01
Publication Date
2026-11-17
Estimated Expiration
2042-11-01

AI Technical Summary

Technical Problem

Existing technologies are insufficient to accurately analyze the conservation of circRNAs across different species, making it difficult to extend the functional mechanisms of circRNAs discovered in animal models to human studies, and lacking effective homology analysis methods.

Method used

By constructing cross-reverse splice site sequences of circRNAs and comparing them with circRNAs of reference species, the conservation of circRNAs among species was analyzed, and homologous circRNAs were identified using blastn alignment technology.

Benefits of technology

This enables more precise identification of homologous human circRNAs, assisting human cell models and clinical research, and providing new targets for disease diagnosis and treatment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115588466B_ABST
    Figure CN115588466B_ABST
Patent Text Reader

Abstract

This invention discloses a method, system, device, and medium for identifying conserved circRNAs in a target species, belonging to the field of bioinformatics. The method includes the following steps: obtaining the circRNA sequence of the target species and the circRNA sequence of a reference species; constructing cross-backsplit site sequences for the circRNA sequences of the target species and the reference species according to whether their lengths are less than a preset length threshold N; aligning the circRNA sequences of the target species and the reference species to obtain a first alignment result; and aligning the cross-backsplit site sequences of the circRNA sequences of the target species with the cross-backsplit site sequences of the circRNA sequences of the reference species to obtain a second alignment result. The intersection of the first and second alignment results is the conserved circRNA. Using this invention, conserved circRNAs similar to human circRNAs can be obtained for some disease-related circRNAs, thereby providing new potential targets for disease diagnosis and treatment.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of bioinformatics technology, specifically relating to a method, system, device, and medium for identifying conserved circRNAs. Background Technology

[0002] Circular RNA (circRNA) is a class of non-coding RNAs with regulatory functions, possessing a closed circular structure formed by covalent bonds. circRNAs lack a free 5' cap and a 3' polyA structure and are insensitive to the exonuclease RNase R, making them more stable than linear RNAs. This gives circRNAs a significant advantage in the development and application of novel clinical diagnostic markers. circRNAs may contain ribosome entry sites (IRES), and can encode proteins through cap-independent translation initiation mediated by IRES elements, IRES-like elements, or N6-methyladenosine (m6A).

[0003] circRNAs were first discovered as virus-like organisms in 1976, and in 1979 they were identified as endogenous RNA splicing products. In 1993, a circular transcript of the Sry gene was discovered in mice. Around 2012, thanks to high-throughput sequencing technology, a large number of circRNAs were discovered, and research on circRNAs entered a period of rapid growth after 2013. Currently, transcriptome sequencing (RNA-seq) has become one of the main techniques for identifying and quantifying circRNAs. Transcriptome sequencing has identified a large number of circRNAs in species such as humans, mice, rats, pigs, Arabidopsis thaliana, rice, and tomatoes, providing important support for the discovery and functional mechanism research of circRNAs.

[0004] circRNAs typically exhibit tissue-specific and cancer-specific expression patterns. Existing research data has demonstrated the potential clinical application value of circRNAs, serving as biomarkers for diagnosis, prognosis, and prediction. The functions of circRNAs have been reported in various cancers and diseases, including colorectal cancer, medulloblastoma, cholangiocarcinoma, neurodegenerative diseases, and non-alcoholic steatohepatitis. Beyond circRNAs, the proteins they encode participate in various important pathophysiological processes in a range of cancers and non-cancer diseases, such as glioblastoma, negative breast cancer, gastric cancer, hepatocellular carcinoma, and Alzheimer's disease. For example, CE-Cad, a protein translated from circular E-cadherin (hsa_circ_0039992), promotes malignant tumor phenotypes in glioblastoma, including proliferation, invasion, and anti-apoptosis. Therefore, circular E-cadherin is currently considered an important target for the treatment of glioblastoma. circRNAs have also become a research hotspot in the field of nucleic acid drugs. Similar to mRNA vaccines, although still in its early stages, circRNA vaccines or circRNA therapies are being actively promoted from the laboratory to industrialization.

[0005] Laboratory animals are an essential element in life science research. Animal disease models are primarily used for experimental physiology and pathology studies, and are also widely used for new drug screening. Researchers typically use animal disease models to study molecular changes and related mechanisms during the occurrence, development, and treatment of a disease, or to obtain information on key candidate molecules by testing clinical samples and then exploring their impact on a biological process or disease development in animal models. Furthermore, the widespread use of transcriptome sequencing has facilitated the creation and development of many high-quality public circRNA databases. However, these databases mainly target model organisms, and most species lack relevant resources. Therefore, when studying relevant candidate molecules, researchers often focus on whether the relevant molecules exist in model organisms and whether there are related studies in model organisms to obtain more reference information to aid in the screening or research of candidate molecules. From animal models to clinical studies or from clinical samples to animal models, and from non-model species to model species, the question of whether the candidate molecule of interest has the same or similar (homologous) molecules in other species may arise. If a candidate molecule exhibits high interspecies conservation, then it is more likely to have significant or conserved functions. For example, if a circRNA that is highly relevant to the occurrence and development of a disease is screened through a mouse disease model, but this circRNA does not exist in humans, then the functional mechanism research in mice will be difficult to extend to human clinical studies. This is because the relevant molecular mechanisms may not exist in humans, thus failing to provide potential targets for disease treatment. Therefore, analyzing the conservation of circRNAs across species is quite necessary for non-model species research and clinical studies.

[0006] Currently, the conservation analysis of circRNAs across species is mainly based on the conservation of parental genes. Since circRNAs are specific splicing products of parental genes, a correlation of circRNA conservation can be established based on parental gene conservation. However, the function of circRNAs is not necessarily related to parental genes, and a single locus may produce multiple circRNAs. Therefore, circRNA correspondence based on parental genes may not be precise enough. Another strategy is to correspond circRNAs of different species based on the location of circRNA loci or backsplit sites. For example, homologous circRNAs can be mapped based on gene coordinate transformation between humans and mice. However, a significant limitation of this strategy is that there is no direct coordinate correspondence between the genomes of many species, thus limiting its species applicability. Moreover, backsplit sites are characteristic sites of circRNAs, and genomic coordinate transformation cannot determine whether similar regions of sequence-similar circRNAs between different species contain or cross backsplit sites. Summary of the Invention

[0007] To address at least one of the aforementioned technical problems, this invention aims to provide a method for identifying conserved circRNAs, capable of analyzing the conservation or similarity relationships between circRNAs of any species and circRNAs of a reference species, and whether the conserved regions contain backsplicing points, i.e., the conservation of backsplicing.

[0008] The first aspect of this invention provides a method for identifying conserved circRNAs in a target species, comprising the following steps:

[0009] S1, obtain the circRNA sequence of the target species and the circRNA sequence of the reference species;

[0010] S2, construct cross-reverse splice site sequences for the circRNA sequences of the target species and the reference species according to whether their lengths are less than a preset length threshold N:

[0011] For circRNAs shorter than N, half the bases from the 5' end are moved to the 3' end to form a sequence across the back splice site;

[0012] For circRNAs of length N or more, move N / 2 bases from the 5' end to the 3' end, and then truncate N bases from the 3' end to form a sequence across the back cleavage site.

[0013] S3, the circRNA sequence of the target species and the circRNA sequence of the reference species are compared to obtain a first comparison result, and the cross-back splice site sequence of the circRNA sequence of the target species is compared with the cross-back splice site sequence of the circRNA of the reference species to obtain a second comparison result. The intersection of the first comparison result and the second comparison result is a conserved circRNA.

[0014] In some embodiments of the present invention, the preset length threshold N is 180 to 260, preferably 200.

[0015] In some embodiments of the present invention, step S1, the step of obtaining the circRNA sequence of the target species, includes:

[0016] RNA samples of the target species were obtained, and after removing ribosomal RNA and / or linear RNA, the remaining RNA was used for library construction and sequencing to obtain the circRNA sequence of the target species.

[0017] Furthermore, after removing sequencing adapter sequences and low-quality sequences from the raw sequencing data, it is aligned to the reference genome of the target species. Reads that are aligned to the reference genome are filtered out, and reads that are not aligned to the genome are non-linearly aligned to the reference genome. Based on the annotation file of the target species, circRNAs are identified, annotated, and their sequences are assembled.

[0018] In some specific embodiments of the present invention, the low-quality sequence refers to reads containing more than 5% of the indeterminate base N, and reads in which more than 20% of the bases have a base quality value Q of less than 10.

[0019] In some specific embodiments of the present invention, clean reads are aligned to the reference genome using TopHat2, reads that are aligned to the reference genome are filtered, and reads that are not aligned to the reference genome are aligned to the reference genome using TopHat-Fusion. Furthermore, based on the alignment results of TopHat-Fusion, CIRCexplorer2 and CIRI are used to identify, quantify, annotate, and assemble circRNA sequences to obtain circRNA sequences.

[0020] In some embodiments of the present invention, the identification of circRNA requires that the number of mismatched bases does not exceed 2, and that the distance between the cleavage sites on the genome is less than 100kb.

[0021] In some embodiments of the present invention, if the target species is an animal, the reference species is a human and / or a mouse, and the circRNA of the reference species is recorded in circBase; if the target species is a plant, the reference species includes Arabidopsis thaliana, rice, and / or tomato, and the circRNA of the reference species is recorded in PlantcircBase.

[0022] In this invention, other circRNA databases, such as circAtlas, CIRCpedia V2, and TSCD, can also be selected, all of which contain valuable circRNA resources. These databases can be integrated to obtain a more detailed human circRNA database. Furthermore, different databases have different update frequencies; therefore, integrating circRNA information from multiple databases is necessary to obtain a wider range of references. Of course, if it is necessary to analyze the conservation of circRNAs in more species, circRNA information from multiple species can be integrated and then compared (or each species can be analyzed separately and then the results integrated). This can obtain homologous circRNA information in multiple species to further analyze circRNA conservation. For circRNAs identified in plants, comparative analysis can also be performed with circRNAs from model plants included in the database. This is beneficial for using model plants to conduct functional mechanism studies or for referencing the relatively abundant background research and database resources of model plants.

[0023] In some embodiments of the present invention, in step S3, if multiple circRNA sequences of the reference species are matched to a single circRNA sequence, the n sequences with the smallest evalues ​​are retained.

[0024] In some specific embodiments of the present invention, blastn is used for alignment, and the alignment threshold evalue is set to 0.00001. Here, n is not less than the number of reference species to analyze the conservation of the target circRNA among a wider range of species.

[0025] In some embodiments of the present invention, step S3 further includes determining whether the cross-backsplicing sequence of the circRNA sequence of the target species and the cross-backsplicing sequence of the circRNA of the reference species cross a backsplicing site. Those skilled in the art can choose any criterion for whether a backsplicing site is crossed; as long as the cleavage site is crossed, it can be considered a cross-backsplicing site. In some specific embodiments of the present invention, a cross-backsplicing site can be determined by the alignment region covering at least m bases flanking the cleavage site, where m = 3 to 15. Preferably, m = 10.

[0026] A second aspect of the present invention provides a system for identifying conserved circRNAs in a target species, comprising:

[0027] The data acquisition module is used to obtain the circRNA sequence of the target species.

[0028] Reference species circRNA sequence storage module, used to store the circRNA sequence of the reference species;

[0029] A cross-reverse cleavage point sequence construction module, connected to both the data acquisition module and the reference species circRNA sequence storage module, is used to construct cross-reverse cleavage point sequences from the circRNA sequences of the target species and the circRNA sequences of the reference species according to whether their lengths are less than a preset length threshold N.

[0030] For circRNAs shorter than N, half the bases from the 5' end are moved to the 3' end to form a sequence across the back splice site;

[0031] For circRNAs of length N or more, move N / 2 bases from the 5' end to the 3' end, and then truncate N bases from the 3' end to form a sequence across the back cleavage site.

[0032] The conserved circRNA identification module, connected to the cross-reverse splice site sequence construction module, is used to align the circRNA sequence of the target species with the circRNA sequence of the reference species, and to align the cross-reverse splice site sequence of the circRNA sequence of the target species with the circRNA sequence of the reference species. The intersection of the alignment results is the conserved circRNA.

[0033] In some embodiments of the present invention, the conserved circRNA identification module further includes determining whether the cross-backsplit site sequence of the circRNA sequence of the target species and the cross-backsplit site sequence of the circRNA of the reference species cross a backsplit site. Those skilled in the art can choose any criterion for whether a backsplit site is crossed; as long as the backsplit site is crossed, it can be considered that a backsplit site has been crossed. In some specific embodiments of the present invention, a cross-backsplit site can be identified by the alignment region covering at least m bases flanking the backsplit site, where m = 3 to 15. Preferably, m = 10.

[0034] A third aspect of the present invention provides a computer device, comprising:

[0035] Memory, used to store computer programs;

[0036] A processor for executing the computer program to implement the steps of the method as described in any of the first aspects of the invention.

[0037] A fourth aspect of the present invention provides a computer-readable storage medium,

[0038] The computer-readable storage medium stores a computer program that, when executed by a processor, implements the steps of the method as described in any of the first aspects of the present invention.

[0039] Beneficial effects of the present invention

[0040] Compared with the prior art, the beneficial effects achieved by the present invention are:

[0041] The method and system for identifying conserved circRNAs provided by this invention construct characteristic cross-backsplit site sequences of circRNAs and then perform blastn alignment with cross-backsplit site sequences of circRNAs from a reference species. This allows for the analysis of circRNA conservation across species or the identification of homologous circRNAs of target circRNAs in one or more species. Blazen alignment of assembled circRNA sequences can also aid in the analysis of homology or conserved circRNAs.

[0042] For some disease-related circRNAs found in animal models, the methods and systems of this invention can be used to more accurately identify homologous human circRNAs, which can assist in human cell models or clinical studies of related molecules, thereby providing new potential targets for disease diagnosis and treatment. Attached Figure Description

[0043] Figure 1 A schematic diagram of the process for identifying conserved circRNAs in an embodiment of the present invention is shown.

[0044] Figure 2 This shows a portion of the human circRNA sequences included in circBase.

[0045] Figure 3 The partial human circRNA sequence across the reverse splice site constructed in Example 1 of this invention is shown.

[0046] Figure 4 The intersection of rat and human circRNA sequences and circRNA sequences across the back splice site is shown in Example 1 of the present invention.

[0047] Figure 5 The diagram shows the alignment of circRNA59 with hsa_circ_0005955 in Embodiment 1 of the present invention.

[0048] Figure 6 The diagram shows the alignment of circRNA1329 with hsa_circ_0138868 in Embodiment 1 of the present invention.

[0049] Figure 7This shows a portion of the plant circRNA sequences recorded in PlantcircBase in Embodiment 2 of the present invention.

[0050] Figure 8 This invention illustrates a portion of the plant circRNA trans-reverse splicing sequences recorded in PlantcircBase in Example 2 of this invention.

[0051] Figure 9 The diagram shows a partial cotton circRNA sequence across the reverse splice site constructed in Example 2 of this invention.

[0052] Figure 10 The intersection of the cotton and PlantcircBase circRNA sequences and the circRNA sequence across the reverse splice site is shown in Example 2 of the present invention.

[0053] Figure 11 The diagram shows the alignment of circRNA340 with gar_circ_000829 in Embodiment 2 of the present invention. Detailed Implementation

[0054] Unless otherwise stated, implied from the context, or as is customary in the art, all parts and percentages in this application are based on weight, and all testing and characterization methods used are concurrent with the filing date of this application. Where applicable, any patent, patent application, or disclosure relating to this application is incorporated herein by reference in its entirety, and its equivalent patent families are also incorporated herein by reference, in particular the definitions of relevant terms in the art disclosed in such documents. If any definition of a specific term disclosed in the prior art is inconsistent with any definition provided in this application, the definition provided in this application shall prevail.

[0055] The numerical ranges used in this application are approximate values ​​and therefore may include values ​​outside the range unless otherwise stated. A numerical range includes all values ​​from the lower limit to the upper limit, increasing by one unit, provided there is an interval of at least two units between any lower and any higher value. For ranges containing values ​​less than 1 or fractions greater than 1 (e.g., 1.1, 1.5, etc.), one unit is appropriately considered as 0.0001, 0.001, 0.01, or 0.1. For ranges containing single digits less than 10 (e.g., 1 to 5), one unit is generally considered as 0.1. These are merely specific examples of what is intended to be expressed, and all possible combinations of values ​​between the listed minimum and maximum values ​​are considered to be clearly described in this application.

[0056] The terms “comprising,” “including,” “having,” and their derivatives do not exclude the presence of any other components, steps, or processes, regardless of whether such other components, steps, or processes are disclosed in this application. To eliminate any doubt, unless expressly stated otherwise, all compositions using the terms “comprising,” “including,” or “having” in this application may contain any additional additives, excipients, or compounds. Conversely, except for those necessary for operational performance, the term “substantially constitutes…” excludes any other components, steps, or processes described below with respect to that term. The term “consisting of…” does not include any components, steps, or processes not specifically described or listed. Unless expressly stated otherwise, the term “or” refers to the individual members listed or any combination thereof.

[0057] To make the technical problems solved by the present invention, the technical solutions and the beneficial effects of the present invention clearer, the present invention will be further described in detail below with reference to the embodiments.

[0058] Example

[0059] The following examples are used to illustrate preferred embodiments of the invention. Those skilled in the art will understand that the techniques disclosed in the examples represent techniques discovered by the inventors that can be used to implement the invention, and therefore can be considered preferred embodiments for implementing the invention. However, those skilled in the art should understand from this specification that many modifications can be made to the specific embodiments disclosed herein, still yielding the same or similar results, without departing from the spirit or scope of the invention.

[0060] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains, and all materials publicly cited herein and referenced by them are incorporated herein by reference.

[0061] Those skilled in the art will recognize, or can learn through routine experimentation, many equivalents of the specific embodiments of the invention described herein. These equivalents will be included in the claims.

[0062] Unless otherwise specified, the molecular biology experimental methods described in the following examples were performed according to the specific methods listed in *Molecular Cloning: A Laboratory Manual* (4th Edition) (J. Sambrook & MR. Green, 2017), or according to the kit and product instructions. Other experimental methods, unless otherwise specified, were conventional methods. Unless otherwise specified, the instruments and equipment used in the following examples were standard laboratory equipment; the experimental materials used in the following examples, unless otherwise specified, were purchased from a regular biochemical reagent store.

[0063] Example 1: circRNA conservation analysis method

[0064] Example 1 uses two rat liver tissue samples as examples to analyze and identify rat circRNAs that are homologous to human circRNAs. The flowchart is as follows. Figure 1 As shown.

[0065] 1. Constructing a standard library for circRNA sequencing

[0066] Total RNA from the samples was isolated and purified using TRIzol according to the manufacturer's instructions. The quantity and purity of total RNA were then quality controlled using a NanoDrop ND-1000, and RNA integrity was checked using a Bioanalyzer 2100. Ribosomal RNA was removed using the Illumina Ribo-Zero Gold rRNA Removal Kit. Circular RNA was further enriched by digesting linear RNA with RNase R (Epicentre), and then a strand-specific transcriptome library was constructed using the dUTP method.

[0067] 2. circRNA sequencing and identification

[0068] (1) The library was sequenced by Illumina Novaseq™ 6000 according to standard procedures in PE150 mode to obtain raw data.

[0069] After removing sequencing adapters and low-quality sequences from the raw data, the steps for filtering low-quality sequences were as follows: removing reads containing adapters, removing reads containing more than 5% N (indeterminate bases), and removing low-quality reads (bases with a quality value Q less than 10 accounting for more than 20% of all reads). Approximately 72.8M and 74.0M high-quality reads were obtained from the two samples, respectively.

[0070] (2) Align the reads with the rat genome using TopHat2 (Rnor_6.0), filter the reads that are aligned with the reference genome, and extract the reads that are not aligned with the genome.

[0071] (3) The unaligned genome reads were non-linearly aligned to the rat genome using TopHat-Fusion (Rnor_6.0), and then circRNAs were identified, quantified, annotated and assembled using CIRCexplorer2 and CIRI, based on the V101 version of the rat Ensembl database genome annotation, to obtain circRNA sequences.

[0072] Identifying circRNAs requires that the number of mismatched bases does not exceed 2, and that the distance between the cleavage sites on the genome is less than 100 kb. Through circRNA sequencing analysis, 1170 and 1213 circRNAs were identified in the two samples, respectively, for a total of 2198 circRNAs.

[0073] 3. Interspecific circRNA sequence reverse splicing sequence alignment

[0074] (1) circRNA sequence organization

[0075] Download human circRNA sequences from circBase (http: / / circbase.org / ). Most of the circRNA sequences currently included in the database are inferred or fitted sequences based on back splice site information and genome annotation files.

[0076] Currently, circBase contains 140,732 circRNAs, some of which have extremely short sequences. Therefore, using 100 nt as a threshold, circRNAs with sequences shorter than 100 nt were filtered out, resulting in 138,379 circRNAs. Of these, 13,927 circRNAs were shorter than 200 nt, and 124,452 circRNAs were longer than or equal to 200 nt. Some sequences are shown below. Figure 2 As shown.

[0077] Of the 2198 circRNAs identified in the two rat samples, 255 were less than 200 nt and 1943 were greater than or equal to 200 nt.

[0078] (2) Constructing a sequence across reverse shear points

[0079] circRNAs were divided into two categories based on their length (whether less than 200 nt) to construct sequences across the reverse splice site:

[0080] ① For circRNA sequences smaller than 200 nt, half of the bases from the 5' end are moved to the 3' end to form a sequence across the reverse cleavage site;

[0081] ② For circRNA sequences of not less than 200 nt; move the 100 nt bases from the 5' end to the 100 nt bases from the 3' end, and then cut off the 200 nt bases from the 3' end to form a 200 nt sequence across the reverse cleavage site.

[0082] The following are examples of cross-back splice site sequences (circRNA1001_junction, circRNA1002_junction) formed by circRNAs less than 200 nt (circRNA1001) and circRNAs greater than 200 nt (circRNA1002), respectively.

[0083] >circRNA1001

[0084] GTAGGTACGTCGAATTCGCACCATTTACCGTAAGTAGGGGCAGCCAACTAACTTGTATGCGTGATGAAA GGGAGGGG GAAAGGAAATGAGAGACTACAGTATAAGAAATTTTTTGATGTCTTCTTGGTTGTTTTATTAAGTTCGAAGGGTCGAG

[0085] The underlined base represents the half-length of the 5' terminal base.

[0086] >circRNA1001_junction

[0087] GAAAGGAAATGAGAGACTACAGTATAAGAAATTTTTTGATGTCTTCTTGGTTGTTTTATTAAGTTCGAAGGGTCGAG GTAGGTACGTCGAATTCGCACCATTTACCGTAAGTAGGGGCAGCCAACTAACTTGTATGCGTGATGAAA GGGAGGGG

[0088] The bases that are half the length of the 5' end are moved to the 3' end.

[0089] >circRNA1002

[0090] GTGTCTCAGGAAGCAGTAGCCCTCCCTCATCCCTCCCCTCTGAGCTGCCTCCCAGATCAGTGAGTTCTT CCATTGAAAGCTCCGGCCATCGCTCAACAGG CCACACAGCGTCCTGGCATGCTGCGTCACCTTCATCTCAAGGTTTCTCCACAAGTCATAGATCTGTAAGTGGATTAAGCAATGCTGTTTCACCTCCACCAAATGTTGCCTTGGGGGATAGTGGAACTGCAGCTGCAGGAATGTTATCTCCATCAAAAACAGACAAGAG AGCTGGAAAGGAGAGATGCAGTGGAAGCAGTGGTGGTATAAGTCTAATGAGAAAATTCACAAGTAGTGGCAAAAAGAAAAGTAAATCCCCACCTCCTTCATACTCCATGGACAATCCTGTTTTTGAAGACTCGACCGTCACATCCAACATGCAGCATGTACACACTAG

[0091] The underscore represents a 100nt base at the 5' end.

[0092] >circRNA1002_junction

[0093] GCAAAAAGAAAAGTAAATCCCCACCTCCTTCATACTCCATGGACAATCCTGTTTTTGAAGACTCGACCGTCACATCCAACATGCAGCATGTACACACTAG GTGTCTCAGGAAGCAGTAGCCCTCCCTCATCCCTCCCCCTTGAGCT GCCTCCCAGATCATGAGTTCTTCCATTGAAAGCTCCGGCCATCGCTCAACAGG

[0094] The bases that are 100 nt long at the 5' end are moved to the 3' end.

[0095] Based on the above description, the cross-reverse splice site sequences of 138,379 circRNAs from circBase were constructed (partial sequences are shown below). Figure 3 (as shown) and the cross-reverse splicing site sequences of 2198 rat circRNAs identified.

[0096] (3) Sequence alignment across reverse shearing points

[0097] The constructed rat circRNA cross-backsplit site sequence was compared with the human circBase circRNA cross-backsplit site sequence using blastn. The comparison threshold evalue was set to 0.00001. If multiple human circRNA cross-backsplit site sequences were matched, the two with the smallest evalue were retained.

[0098] The identified rat circRNA sequences were compared with human circBase circRNA sequences using blastn. The comparison threshold evalue was set to 0.00001. If the rat circRNA matched multiple human circRNA sequences, the two with the smallest evalue were retained.

[0099] (4) Comparison results analysis

[0100] To determine whether the rat circRNA sequence crossing the back splice site crosses the back splice site with the human circRNA sequence crossing the back splice site in circBase, the criterion is that the aligned region covers 10 bases to the left and right of the back splice site.

[0101] The blastn alignment results of circRNA sequences are shown in Table 1:

[0102] Table 1. Results of blastn sequence alignment for circRNA.

[0103]

[0104]

[0105] Note:

[0106] Query: Query sequence ID identifier, i.e., the ID of the rat circRNA;

[0107] Query_length: The length of the query sequence, i.e., the length of the rat circRNA sequence;

[0108] Subject: The target sequence ID identifier in the alignment, i.e., the ID of the human circRNA in circBase;

[0109] Subject_length: Target sequence length, i.e., the sequence length of human circRNA in circBase;

[0110] %identity: The percentage of sequence alignment consistency;

[0111] Alignment length: The length of the alignment region that matches the alignment;

[0112] Mismatches: The number of mismatches in the comparison region;

[0113] Gap openings: The number of gaps in the comparison area;

[0114] q.start: The starting position of the comparison region on the query sequence;

[0115] q.end: The endpoint of the alignment region on the query sequence;

[0116] s.start: The starting point of the alignment region on the target sequence;

[0117] s.end: The termination site of the alignment region on the target sequence;

[0118] e-value: The expected value of the comparison result, with a threshold of 0.00001;

[0119] Bit score: The bit score value of the comparison result.

[0120] The blastn alignment results of circRNA sequences across the reverse splicing site are shown in Table 2.

[0121] Table 2. Alignment results of blastn sequences across the circRNA reverse splice site.

[0122]

[0123]

[0124]

[0125]

[0126] Note:

[0127] Queryjunction: The query sequence ID identifier, which is the ID of the sequence across the back splice site formed by rat circRNA;

[0128] Queryjunctionlength: The query sequence length, which is the sequence length of the rat circRNA sequence across the back splice site;

[0129] Subjectjunction: The target sequence ID identifier in the alignment, i.e., the ID of the sequence across the reverse splice site formed by human circRNA in circBase;

[0130] Subjectjunctionlength: The length of the target sequence, i.e., the sequence length of the sequence across the back splice point formed by human circRNA in circBase;

[0131] q.span: Whether the Queryjunction and Subjectjunction match sequence intervals cross the back shear point of the Queryjunction, Y indicates crossing; s.span:

[0132] The queryjunction and subjectjunction match whether the sequence interval crosses the reverse shear point of the subjectjunction, where Y indicates that it crosses.

[0133] Through circRNA sequence alignment, 1598 out of 2198 rat circRNAs were found to have similar sequences in circBase human circRNA (evalue < 0.00001). Through cross-reverse splice site sequence alignment, 1256 circRNAs were found to have similar sequences in the cross-reverse splice site of circBase human circRNA. The intersection of the two methods yielded 1251 circRNAs. Figure 4 As shown.

[0134] While circRNA sequence alignment can analyze the similarity between circRNAs, it primarily reflects the similarity of parental genes or local parental gene sequences. Since the main characteristic of circRNAs is the backsplitting point, this embodiment uses the alignment results of sequences near the backsplitting point as the primary basis for screening conserved or homologous circRNAs or circRNAs from corresponding model organisms (e.g., humans). circRNA sequence alignment can also serve as supplementary reference information to examine the degree of similarity between sequences outside the backsplitting point, thus identifying more conserved circRNAs.

[0135] Based on the q.span and s.span information, among the 595 rat circRNA alignments, 618 rat circRNA-human circRNA pairs showed similar regions that crossed their respective backsplicing sites, indicating significant backsplicing conservation. Because the alignment analysis retained the two lowest evalues ​​and because the same locus can be transcribed and spliced ​​to generate multiple circRNAs that may have the same or similar backsplicing sites, one rat circRNA might align to two human circRNAs; conversely, multiple rat circRNAs might align to the same human circRNA. Therefore, the number of rat circRNA-human circRNA pairs in the alignment results is greater than the total number of rat circRNAs and human circRNAs combined.

[0136] Two alignment mapping relationships were selected as examples: circRNA59 with hsa_circ_0005955 and circRNA1329 with hsa_circ_0138868. The alignment diagrams are shown below. Figure 5 and Figure 6 As shown.

[0137] Rat circRNA59 originates from the rat Dyrk1a locus, and circRNA1329 originates from the rat RGD1311595 locus, similar to the KIAA2026 protein; while hsa_circ_0005955 originates from the human DYRK1A locus, and hsa_circ_0138868 originates from the human KIAA2026 locus. circRNA59 and circRNA1329 are similar to a reverse-spliced ​​circRNA derived from a human homolog (hsa_circ_0005955 and hsa_circ_0138868), indicating their conservation between humans and rats. If these conserved circRNAs play an important role in rat disease models, their research can be easily extended to clinical studies to explore the potential roles of their homologous circRNAs in human diseases.

[0138] Example 2: Method for analyzing the conservation of plant circRNA

[0139] This embodiment uses six cotton leaves as an example to analyze and identify circRNAs in cotton that are homologous to those in other plants or conserved in plants, similarly referring to... Figure 1 The procedure differs from Example 1 in that the circRNA sequencing library is a strand-specific transcriptome library constructed after removing ribosomal RNA.

[0140] 1. Constructing a standard library for circRNA sequencing

[0141] Total RNA from the samples was isolated and purified using TRIzol according to the manufacturer's instructions. The quantity and purity of the total RNA were then quality controlled using a NanoDrop ND-1000, and RNA integrity was checked using a Bioanalyzer 2100. Ribosomal RNA was removed using the Illumina Ribo-Zero Gold rRNA Removal Kit, and strand-specific transcriptome libraries were constructed using the dUTP method.

[0142] 2. circRNA sequencing and identification

[0143] (1) The library was sequenced by Illumina Novaseq™ 6000 according to standard procedures in PE150 mode to obtain raw data.

[0144] After removing sequencing adapters and low-quality sequences from the raw data, the steps for filtering low-quality sequences were as follows: removing reads containing adapters, removing reads containing more than 5% N (indeterminate bases), and removing low-quality reads (bases with a quality value Q less than 10 accounting for more than 20% of all reads). Approximately 72.8M and 74.0M high-quality reads were obtained from the two samples, respectively.

[0145] (4) Align the reads with the cotton genome using Hisat2 (HAU_G.hirsutum_AD1genome_v1.1), filter the reads that are aligned with the reference genome, and extract the reads that are not aligned with the genome.

[0146] (5) The unaligned genome reads were non-linearly aligned to the cotton genome (HAU_G.hirsutum_AD1genome_v1.1) using TopHat-Fusion. Then, circRNAs were identified, quantified, annotated, and assembled using CIRCexplorer2 and CIRI, based on the genome annotation of HAU_G.hirsutum_AD1genome_v1.1, to obtain circRNA sequences.

[0147] Identifying circRNAs requires that the number of mismatched bases does not exceed 2, and that the distance between the cleavage sites on the genome is less than 100 kb. Through circRNA sequencing analysis, 160, 154, 175, 185, 219, and 221 circRNAs were identified in the six samples, respectively, for a total of 792 circRNAs.

[0148] 3. Interspecific circRNA sequence reverse splicing sequence alignment

[0149] (1) circRNA sequence organization

[0150] Download plant circRNA sequences from PlantcircBase (http: / / ibi.zju.edu.cn / plantcircbase / index.php, version 5.0 as an example). PlantcircBase contains circRNA sequences and transsplice sequences from 19 plant species, including Arabidopsis thaliana, rice, wheat, tobacco, cotton, cucumber, and tea. Download circRNA sequences and transsplice sequences from multiple or all species directly from the PlantcircBase database for subsequent conservation analysis. This example uses all species; download all circRNA sequences and transsplice sequences and integrate them into a FASTA format file containing sequence information for all species.

[0151] Since PlantcircBase directly provides cross-reverse splice site sequences, it is not necessary to construct cross-reverse splice sequences based on circRNA sequences. A total of 121,971 circRNAs and cross-reverse splice site sequences from 19 species were downloaded. The circRNA sequences ranged in length from 15 to 10,268,072 nt, and some sequences are shown below. Figure 7 As shown, the sequence span across the back shear point ranges from 15 to 200 nt, and some sequences are as follows: Figure 8 As shown.

[0152] Of the 792 circRNAs identified in the six cotton samples, 104 were less than 200 nt and 688 were greater than or equal to 200 nt.

[0153] (2) Constructing a sequence across reverse shear points

[0154] The identified circRNAs were divided into two categories based on their length (whether they were less than 200 nt) to construct cross-reverse splice site sequences:

[0155] ① For circRNA sequences smaller than 200 nt, half of the bases from the 5' end are moved to the 3' end to form a sequence across the reverse cleavage site;

[0156] ② For circRNA sequences of not less than 200 nt; move the 100 nt bases from the 5' end to the 100 nt bases from the 3' end, and then cut off the 200 nt bases from the 3' end to form a 200 nt sequence across the reverse cleavage site.

[0157] The construction method is the same as that used in Example 1 for constructing cross-reverse cleavage site sequences of rat circRNA. Based on the above description, cross-reverse cleavage site sequences of the 792 identified cotton circRNAs were constructed, some of which are shown below. Figure 9 As shown.

[0158] (3) Sequence alignment across reverse shearing points

[0159] The constructed cotton circRNA cross-backsplit site sequence was compared with the PlantcircBase circRNA cross-backsplit site sequence using BLASTN. The comparison threshold evalue was set to 0.00001. If multiple PlantcircBase circRNA cross-backsplit site sequences were matched, the two with the smallest evalue were retained (as an example; if it is necessary to analyze the conservation of a wider range of species and explore how many species in the database have homologous circRNAs, the 20 with the smallest evalue can be retained; or the sequence can be compared with each species separately, and the one with the smallest evalue for each species can be retained).

[0160] The identified cotton circRNA sequences were compared with PlantcircBase circRNA sequences using blastn alignment. The alignment threshold evalue was set to 0.00001. If the cotton circRNA matched with multiple PlantcircBase circRNAs, the two with the lowest evalues ​​were retained (as an example; if it is necessary to analyze the conservation of a wider range of species and explore how many species in the database have homologous circRNAs, the 20 with the lowest evalues ​​can be retained; or the sequences can be compared with each species separately, and the sequence with the lowest evalue for each species can be retained).

[0161] 4) Comparison Result Analysis

[0162] To determine whether the cotton circRNA sequence crossing the back cleavage site and the PlantcircBase circRNA sequence crossing the back cleavage site cross the back cleavage site, the criterion is that the aligned regions cover 10 bases to the left and right of the back cleavage site.

[0163] The blastn alignment results of circRNA sequences are shown in Table 3:

[0164] Table 3. Results of blastn alignment of circRNA sequences.

[0165]

[0166]

[0167] Note:

[0168] Query: Query sequence ID identifier, i.e., the ID of the cotton circRNA;

[0169] Query_length: The length of the query sequence, i.e., the sequence length of the cotton circRNA;

[0170] Subject: The target sequence ID identifier in the alignment, i.e., the ID of PlantcircBasecircRNA;

[0171] Subject_length: The length of the target sequence, i.e., the sequence length of PlantcircBasecircRNA;

[0172] %identity: The percentage of sequence alignment consistency;

[0173] Alignment length: The length of the alignment region that matches the alignment;

[0174] Mismatches: The number of mismatches in the comparison region;

[0175] Gap openings: The number of gaps in the comparison area;

[0176] q.start: The starting position of the comparison region on the query sequence;

[0177] q.end: The endpoint of the alignment region on the query sequence;

[0178] s.start: The starting point of the alignment region on the target sequence;

[0179] s.end: The termination site of the alignment region on the target sequence;

[0180] e-value: The expected value of the comparison result, with a threshold of 0.00001;

[0181] Bit score: The bit score value of the comparison result.

[0182] The blastn alignment results of circRNA sequences across the reverse splicing site are shown in Table 4.

[0183] Table 4. Alignment results of blastn sequences across the circRNA reverse splice site.

[0184]

[0185]

[0186] Note:

[0187] Queryjunction: The query sequence ID identifier, i.e., the ID of the sequence across the back splice site formed by cotton circRNA;

[0188] Queryjunctionlength: The query sequence length, which is the sequence length of the cotton circRNA sequence across the back splice point;

[0189] Subjectjunction: The target sequence ID identifier in the alignment, i.e., the ID of the sequence across the reverse splice site of PlantcircBase circRNA;

[0190] Subjectjunctionlength: The length of the target sequence, i.e., the length of the sequence across the reverse splice site of PlantcircBase circRNA;

[0191] q.span: Whether the Queryjunction and Subjectjunction match sequence intervals cross the back shear point of the Queryjunction, Y indicates crossing; s.span:

[0192] The queryjunction and subjectjunction match whether the sequence interval crosses the reverse shear point of the subjectjunction, where Y indicates that it crosses.

[0193] Through circRNA sequence alignment, 562 out of 792 cotton circRNAs were found to have similar sequences in PlantcircBase circRNA (evalue < 0.00001). Through cross-backsplice sequence alignment, 352 circRNAs had cross-backsplice sequences that aligned to similar sequences in PlantcircBase circRNA. The intersection of the two methods yielded 349 circRNAs. Figure 10 As shown.

[0194] Based on the q.span and s.span information, among the 172 cotton circRNA alignments, 268 cotton circRNA-PlantcircBase circRNA pairs showed similar regions that crossed their respective backsplicing points, indicating significant backsplicing conservation. Since the alignment analysis retained the two alignments with the lowest evalues, and because the same locus can be transcribed and spliced ​​to generate multiple circRNAs that may have the same or similar backsplicing points, a single cotton circRNA may align to multiple PlantcircBase circRNAs; conversely, multiple cotton circRNAs may align to the same PlantcircBase circRNA. Therefore, in the alignment results, the number of cotton circRNA-PlantcircBase circRNA pairs is greater than the number of cotton circRNAs and the number of PlantcircBase circRNAs. Unlike Example 1, PlantcircBase includes information on three types of cotton circRNAs: Asian cotton (Gossypium arboreum, gar), upland cotton (Gossypium hirsutum, ghi), and cotton (Gossypium raimondii, gra). In the analysis, 241 circRNA backsplicing sequences aligned with one of these three cotton species, indicating higher similarity or conservation of circRNAs within the same genus (Gossypium) than between different genera. Some circRNAs are conserved across different species; for example, sequence-similar circRNAs and / or cross-backsplicing sequence-similar circRNAs were found in Arabidopsis thaliana, tomato, and maize. If Gossypium species are excluded, further analysis could be conducted to determine whether these highly conserved circRNAs within the same genus are also conserved in other plants. In addition, sequence alignment can also reveal which of the identified circRNAs are already included in the database (as shown in Table 5). For example, circRNA102 is highly similar to ghi_circ_000445 and ghi_circ_000446 in PlantcircBase; while circRNA125, circRNA775, and circRNA776 correspond to ghi_circ_000306, ghi_circ_000001, and ghi_circ_000007, respectively.

[0195] Table 5. Partial results of blastn alignment of circRNA sequences.

[0196]

[0197]

[0198] Note:

[0199] Query: Query sequence ID identifier, i.e., the ID of the cotton circRNA;

[0200] Query_length: The length of the query sequence, i.e., the sequence length of the cotton circRNA;

[0201] Subject: The target sequence ID identifier in the alignment, i.e., the ID of PlantcircBasecircRNA;

[0202] Subject_length: The length of the target sequence, i.e., the sequence length of PlantcircBasecircRNA;

[0203] %identity: The percentage of sequence alignment consistency;

[0204] Alignment length: The length of the alignment region that matches the alignment;

[0205] Mismatches: The number of mismatches in the comparison region;

[0206] Gap openings: The number of gaps in the comparison area;

[0207] q.start: The starting position of the comparison region on the query sequence;

[0208] q.end: The endpoint of the alignment region on the query sequence;

[0209] s.start: The starting point of the alignment region on the target sequence;

[0210] s.end: The termination site of the alignment region on the target sequence;

[0211] e-value: The expected value of the comparison result, with a threshold of 0.00001;

[0212] Bit score: The bit score value of the comparison result.

[0213] Using the alignment mapping relationship between circRNA340 and gar_circ_000829 as an example, the alignment diagram is shown below. Figure 5 As shown.

[0214] Examples 1 and 2, using rats and cotton as examples respectively, were used to analyze the conservation of animal and plant circRNAs. These examples also correspond to two commonly used circRNA library preparation methods: RNase R digestion and ribosomal RNA removal. The analytical methods are compatible with animal, plant, and extended species, and support different circRNA library preparation and analysis procedures.

[0215] All documents mentioned in this invention are incorporated herein by reference as if each document were individually incorporated by reference. Furthermore, it should be understood that after reading the foregoing teachings of this invention, those skilled in the art can make various alterations or modifications to this invention, and these equivalent forms also fall within the scope defined by the appended claims.

Claims

1. A method for identifying conserved circRNAs in a target species, characterized in that, Includes the following steps: S1, obtain the circRNA sequence of the target species and the circRNA sequence of the reference species; S2, construct cross-reverse splice site sequences for the circRNA sequences of the target species and the reference species according to whether their lengths are less than a preset length threshold N: For circRNAs shorter than N, half the bases from the 5' end are moved to the 3' end to form a sequence across the back splice site; For circRNAs of length N or more, move N / 2 bases from the 5' end to the 3' end, and then truncate N bases from the 3' end to form a sequence across the back cleavage site. The preset length threshold N is 180~260. S3, the circRNA sequence of the target species and the circRNA sequence of the reference species are aligned to obtain a first alignment result, and the cross-backsplit site sequence of the circRNA sequence of the target species is aligned with the cross-backsplit site sequence of the circRNA sequence of the reference species to obtain a second alignment result. The intersection of the first alignment result and the second alignment result is the conserved circRNA. In step S3, it is also included to determine whether the similar region of the cross-reverse cleavage sequence of the target species' circRNA sequence and the cross-reverse cleavage sequence of the reference species' circRNA crosses the reverse cleavage point. If it crosses the reverse cleavage point, the alignment result is retained. The criterion for the determination is that the alignment region covers at least m bases on both sides of the reverse cleavage point, where m is 3-15. Furthermore, in step S3, if multiple circRNA sequences of the reference species are matched to a single circRNA sequence, the n sequences with the smallest evalues ​​are retained, where n is not less than the number of reference species.

2. The method for identifying conserved circRNAs of a target species according to claim 1, characterized in that, Step S1, the steps for obtaining the circRNA sequence of the target species, include: RNA samples of the target species were obtained, and after removing ribosomal RNA and / or linear RNA, the remaining RNA was used for library construction and sequencing to obtain the circRNA sequence of the target species.

3. The method for identifying conserved circRNAs of a target species according to claim 2, characterized in that, After removing sequencing adapter sequences and low-quality sequences from the raw sequencing data, it is aligned to the reference genome of the target species. Reads that are aligned to the reference genome are filtered out, and reads that are not aligned to the genome are non-linearly aligned to the reference genome. Based on the annotation file of the target species, circRNAs are identified, annotated, and their sequences are assembled.

4. The method for identifying conserved circRNAs of a target species according to claim 1, characterized in that, If the target species is an animal, then the reference species is a human and / or a mouse; if the target species is a plant, then the reference species includes Arabidopsis thaliana, rice, and / or tomato.

5. A system for identifying conserved circRNAs in a target species, characterized in that, include: The data acquisition module is used to obtain the circRNA sequence of the target species. Reference species circRNA sequence storage module, used to store the circRNA sequence of the reference species; A cross-reverse cleavage point sequence construction module, connected to both the data acquisition module and the reference species circRNA sequence storage module, is used to construct cross-reverse cleavage point sequences from the circRNA sequences of the target species and the circRNA sequences of the reference species according to whether their lengths are less than a preset length threshold N. For circRNAs shorter than N, half the bases from the 5' end are moved to the 3' end to form a sequence across the back splice site; For circRNAs of length N or more, move N / 2 bases from the 5' end to the 3' end, and then truncate N bases from the 3' end to form a sequence across the back cleavage site. The preset length threshold N is 180~260. A conserved circRNA identification module, connected to the cross-reverse splice site sequence construction module, is used to align the circRNA sequences of the target species and the reference species, and to align the cross-reverse splice site sequences of the target species' circRNA sequences with those of the reference species' circRNA sequences. The intersection of the alignment results represents the conserved circRNAs. If, for a single circRNA sequence, multiple circRNA sequences from the reference species are matched, the top n sequences with the smallest evalue values ​​are retained, where n is not less than the number of reference species. The conserved circRNA identification module is also used to determine whether the similar region of the cross-reverse cleavage sequence of the circRNA sequence of the target species and the cross-reverse cleavage sequence of the circRNA of the reference species crosses the reverse cleavage point. If it crosses the reverse cleavage point, the alignment result is retained. The criterion for judgment is that the alignment region covers at least m bases on both sides of the reverse cleavage point, where m is 3-15.

6. A computer device, characterized in that, include: Memory, used to store computer programs; A processor for implementing the steps of the method as described in any one of claims 1 to 4 when executing the computer program.

7. A computer-readable storage medium, characterized in that, The computer-readable storage medium stores a computer program that, when executed by a processor, implements the steps of the method as described in any one of claims 1-4.